Morgan Stanley’s NeuroSense Therapeutics NRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $151K | Buy |
79,900
+29,399
| +58% | +$55.6K | ﹤0.01% | 5961 |
|
|
2025
Q1 | $47K | Sell |
50,501
-52,080
| -51% | -$48.4K | ﹤0.01% | 6292 |
|
|
2024
Q4 | $123K | Buy |
+102,581
| New | +$123K | ﹤0.01% | 5975 |
|
|
2024
Q3 | – | Sell |
-1,500
| Closed | -$1.68K | – | 7997 |
|
|
2024
Q2 | $1.68K | Hold |
1,500
| – | – | ﹤0.01% | 7089 |
|
|
2024
Q1 | $2.73K | Sell |
1,500
-1,500
| -50% | -$2.73K | ﹤0.01% | 7019 |
|
|
2023
Q4 | $2.36K | Buy |
+3,000
| New | +$2.36K | ﹤0.01% | 7117 |
|
|
2023
Q1 | – | Sell |
-4
| Closed | -$5 | – | 7796 |
|
|
2022
Q4 | $5 | Hold |
4
| – | – | ﹤0.01% | 7832 |
|
|
2022
Q3 | $0 | Buy |
+4
| New | – | ﹤0.01% | 7819 |
|